Detalhe da pesquisa
1.
miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.
Blood;
137(18): 2481-2494, 2021 05 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33171493